Article Rapid isolation of extracellular vesicles from stem cell conditioned medium using osmosis-driven filtration

Casey Y. Huang (a Department of Material Science and Engineering, National Taiwan University of Science and Technology) ; Helen Nguyen ; David J. Lundy ; James. J Lai

Collection

Citation
Casey Y. Huang, Helen Nguyen, David J. Lundy, James. J Lai. Rapid isolation of extracellular vesicles from stem cell conditioned medium using osmosis-driven filtration. Science and Technology of Advanced Material. 2025, 26 (1), 2485668. https://doi.org/10.48505/nims.5437

Description:

(abstract)

Extracellular vesicles (EVs) hold significant promise as biomarkers and therapeutics, yet their isolation remains challenging due to their low abundance and complex sample matrices. Here, we introduce EV-Osmoprocessor (EVOs), a novel device that leverages osmosis-driven filtration for rapid and efficient EV isolation. EVOs employs a high osmolarity polymer solution to concentrate EVs while simultaneously removing smaller contaminants. Compared to traditional methods such as ultracentrifugation and precipitation, EVOs offers speed and convenience, achieving a 50-fold volume reduction in under 2 h. Our results show that EVOs retained EVs and removed >99% albumin from the cell conditioned culture medium (CCM). The isolated EVs exhibited a particle size distribution centered around 140 nm, which was very similar to EVs isolated via precipitation or ultracentrifugation. The standalone EVOs process achieved a particle:protein ratio (EV purity) of ~107 particles/µg protein. Comprehensive characterization, including cryo-electron microscopy, validation of protein markers and known miRNA cargo confirmed the successful isolation of EVs. Functional assays, based on protection of cardiomyocytes from hypoxia/reoxygenation injury, demonstrated the bioactivity of EVOs-isolated EVs. Furthermore, we show that EVOs can be used to concentrate 30 ml of CCM into a 0.5 ml solution, which was then further processed with size-exclusion chromatography (SEC), improving EV purity to ~109 particles/µg protein. This work establishes EVOs as a promising tool for EV research and clinical applications, offering a streamlined approach to EV isolation with enhanced analytical performance.

Rights:

Keyword: Exosome, mesenchymal stromal cell, cardiomyocyte, bioprocessing, polymer

Date published: 2025-12-31

Publisher: Taylor & Francis

Journal:

  • Science and Technology of Advanced Material (ISSN: 14686996) vol. 26 issue. 1 2485668

Funding:

Manuscript type: Author's version (Accepted manuscript)

MDR DOI: https://doi.org/10.48505/nims.5437

First published URL: https://doi.org/10.1080/14686996.2025.2485668

Related item:

Other identifier(s):

Contact agent:

Updated at: 2025-04-17 16:53:31 +0900

Published on MDR: 2025-04-20 17:17:32 +0900